|
|
|
Insider
Information: |
Silvernail Lauren P |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
207,068 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,016,525 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
207,068 |
|
|
Total
Value |
$2,016,525 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-60.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ISTA Pharmaceuticals Inc |
ISTA |
CFO & VP Corporate Dev... |
2012-06-06 |
0 |
2005-05-12 |
0 |
Premium* |
|
Revance Therapeutics, Inc. |
RVNC |
CFO & CBO |
2018-05-22 |
65,497 |
2014-05-19 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
See Remarks |
2022-05-18 |
141,571 |
2018-05-29 |
0 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2023-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2017-11-07 |
4 |
AS |
$26.83 |
$268,267 |
D/D |
(10,000) |
49,006 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-07 |
4 |
AS |
$31.50 |
$315,000 |
D/D |
(10,000) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-09 |
4 |
AS |
$32.50 |
$325,000 |
D/D |
(10,000) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-13 |
4 |
AS |
$34.50 |
$892,412 |
D/D |
(25,867) |
72,954 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, CBO & Secretary |
|
2018-03-22 |
4 |
AS |
$30.85 |
$105,839 |
D/D |
(3,431) |
68,371 |
0 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO & CBO |
|
2018-05-22 |
4 |
AS |
$30.25 |
$86,924 |
D/D |
(2,874) |
65,497 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-01-25 |
4 |
AS |
$7.46 |
$20,135 |
D/D |
(2,699) |
90,689 |
0 |
% |
|
EOLS |
Evolus Inc |
See Remarks |
|
2021-08-10 |
4/A |
AS |
$11.18 |
$159,774 |
D/D |
(14,293) |
166,396 |
0 |
- |
|
EOLS |
Evolus Inc |
See Remarks |
|
2022-03-08 |
4 |
AS |
$9.73 |
$99,121 |
D/D |
(10,192) |
209,775 |
0 |
% |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2005-05-12 |
4 |
B |
$7.51 |
$37,699 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-12-09 |
4 |
B |
$0.63 |
$10,698 |
D/D |
17,000 |
43,353 |
2.74 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-08-11 |
4 |
B |
$4.28 |
$10,705 |
D/D |
2,500 |
96,505 |
2.74 |
- |
|
RVNC |
Revance Therapeutics, Inc... |
CFO, Secretary & EVP Corp Dev. |
|
2014-12-11 |
4 |
B |
$17.73 |
$17,383 |
D/D |
980 |
14,980 |
2.74 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2007-02-16 |
4 |
D |
$8.11 |
$4,055 |
D/D |
(500) |
17,100 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-04 |
4 |
D |
$5.27 |
$4,379 |
D/D |
(831) |
16,269 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-04 |
4/A |
D |
$5.27 |
$3,937 |
D/D |
(747) |
16,353 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2008-02-19 |
4 |
D |
$4.56 |
$2,280 |
D/D |
(500) |
26,269 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2010-02-02 |
4 |
D |
$3.63 |
$2,791 |
D/D |
(769) |
51,584 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2010-02-03 |
4 |
D |
$3.60 |
$3,560 |
D/D |
(989) |
59,595 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2010-02-08 |
4 |
D |
$3.59 |
$3,454 |
D/D |
(962) |
58,633 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2010-02-16 |
4 |
D |
$3.96 |
$2,031 |
D/D |
(513) |
58,120 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-02-02 |
4 |
D |
$6.15 |
$10,344 |
D/D |
(1,682) |
56,438 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-02-03 |
4 |
D |
$6.20 |
$5,865 |
D/D |
(946) |
55,492 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
Chief Financial Officer |
|
2011-02-08 |
4 |
D |
$7.48 |
$8,258 |
D/D |
(1,104) |
65,338 |
0 |
- |
|
ISTA |
ISTA Pharmaceuticals Inc |
CFO |
|
2011-05-10 |
4 |
D |
$11.26 |
$382,840 |
D/D |
(34,000) |
94,005 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|